Oracle Investment Management as of Dec. 31, 2018
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 15 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 33.4 | $100M | 2.0M | 48.82 | |
| Amarin Corporation (AMRN) | 24.1 | $72M | 5.3M | 13.61 | |
| Tesaro | 11.7 | $35M | 472k | 74.25 | |
| Pacific Biosciences of California (PACB) | 11.1 | $33M | 4.5M | 7.40 | |
| Opko Health (OPK) | 3.7 | $11M | 3.7M | 3.01 | |
| Contrafect | 2.9 | $8.8M | 5.7M | 1.53 | |
| Motus Gi Hldgs Incorporated | 2.9 | $8.6M | 2.8M | 3.11 | |
| Biohaven Pharmaceutical Holding | 2.2 | $6.5M | 175k | 36.98 | |
| Soleno Therapeutics | 2.1 | $6.3M | 3.7M | 1.71 | |
| Biolase | 2.0 | $6.1M | 6.2M | 0.99 | |
| Agenus (AGEN) | 1.1 | $3.2M | 1.4M | 2.38 | |
| Accelr8 Technology | 1.1 | $3.2M | 4.8M | 0.66 | |
| Vermillion | 1.0 | $2.9M | 9.8M | 0.30 | |
| Biogen Idec (BIIB) | 0.6 | $1.9M | 6.4k | 302.45 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $304k | 53k | 5.74 |
